To the Editor: I read with interest the article by Xi et al. that IL-26 is a novel prognostic factor for hepatocellular carcinoma (HCC) after resection [1]. I have some comments on it.First, investigation of prognosti...To the Editor: I read with interest the article by Xi et al. that IL-26 is a novel prognostic factor for hepatocellular carcinoma (HCC) after resection [1]. I have some comments on it.First, investigation of prognostic factors is only generating hypothesis which must be confirmed in a prospective series.展开更多
To the Editor: We thank Dr. Braillon for the thoughtful remarks regarding prognostic impact of interleukin (IL)-26 on patients with hepatocellular carcinoma (HCC) undergoing surgical resection [1]. This study drew a c...To the Editor: We thank Dr. Braillon for the thoughtful remarks regarding prognostic impact of interleukin (IL)-26 on patients with hepatocellular carcinoma (HCC) undergoing surgical resection [1]. This study drew a conclusion that relative high expression of IL-26 is an independent prognostic factor for HCC patients after resection.展开更多
文摘To the Editor: I read with interest the article by Xi et al. that IL-26 is a novel prognostic factor for hepatocellular carcinoma (HCC) after resection [1]. I have some comments on it.First, investigation of prognostic factors is only generating hypothesis which must be confirmed in a prospective series.
文摘To the Editor: We thank Dr. Braillon for the thoughtful remarks regarding prognostic impact of interleukin (IL)-26 on patients with hepatocellular carcinoma (HCC) undergoing surgical resection [1]. This study drew a conclusion that relative high expression of IL-26 is an independent prognostic factor for HCC patients after resection.